Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women.
about
Pre-eclampsia part 1: current understanding of its pathophysiology.Maternal and fetoplacental hypoxia do not alter circulating angiogenic growth effectors during human pregnancy.Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy.Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.Endothelial Dysfunction in Severe Preeclampsia is Mediated by Soluble Factors, Rather than Extracellular Vesicles.Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1α pathway.Angiogenic factors and preeclampsia.Glyceryl trinitrate inhibits hypoxia-induced release of soluble fms-like tyrosine kinase-1 and endoglin from placental tissuesAspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1.Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice.Regulation of soluble fms-like tyrosine kinase-1 production in response to placental ischemia/hypoxia: role of angiotensin II.The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancyCirculating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of PreeclampsiaHypoxia-Mediated Soluble Fms-Like Tyrosine Kinase 1 Increase Is Not Attenuated in Interleukin 6-Deficient MiceTranscriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia.Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α.Differential placental methylation and expression of VEGF, FLT-1 and KDR genes in human term and preterm preeclampsia.Vascular pool of releasable soluble VEGF receptor-1 (sFLT1) in women with previous preeclampsia and uncomplicated pregnancy.Dynamic proteome in enigmatic preeclampsia: an account of molecular mechanisms and biomarker discovery.The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study.Human endometrial stromal cell plasticity: Reversible sFlt1 expression negatively coincides with decidualization.Feto-maternal correlation of PTX3, sFlt-1 and PlGF in physiological and pre-eclamptic pregnancies.Preeclampsia and soluble fms-like tyrosine kinase 1.Circulating angiogenic factors and their association with birth outcomes in preeclampsia.A Maternally Sequestered, Biopolymer‐Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia.Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia.VEGF vascularization pathway in human intervertebral disc does not change during the disc degeneration process.
P2860
Q33416340-453C3C0B-6D25-4A63-84FD-C67570186BBBQ33826353-D73C98D8-23FE-48F0-BBE5-DDD5A01D65A4Q33894600-B5D4EB0E-A11F-4804-93A4-5CA0C4BFB92FQ33899627-809B42C6-F1B6-4A60-A504-DD7D333184E3Q33918999-F3C29097-9E88-4C8A-9C4D-CAB9C61E5EFAQ34365552-B053D6E0-AF91-4B1E-8482-D9907994589EQ34714082-C0436910-A50F-49D2-AE5F-69A6CC38C84DQ35070633-91D6BDC9-6809-4FC6-9AAD-4EF626927653Q35178348-000C268A-6404-4FA1-9C66-10D772E36E9EQ35362708-EE718420-EABF-49A6-AF11-8D68FC11B6FAQ35363716-AD14F9E4-431A-4E0A-A379-EFA752BEE948Q35647966-E9A5392B-A85F-4662-9573-7983BA75C69FQ35813842-C87BA53F-F20A-4469-BD58-E93525679752Q35853182-E3D8B7FC-0F32-49BF-91DA-80EEB2BF898AQ35871466-15268234-7536-450E-8B44-898F3633475FQ36528002-0B931E07-27D0-47E2-AD25-C9A1EC9C1E13Q36808609-32BF37D9-06A6-41F2-BE1E-4399F24700C1Q37616832-AE34006D-D2DC-48F5-BD9B-23B220C6693BQ37996960-2809498B-F007-4428-80F5-CBD9CEFF0EACQ38664824-635818AC-8A64-4960-A9D7-7B0C3E7F01B0Q38791930-DA382576-30B5-4397-9765-B2002FAC74B9Q40184016-E6DC2612-CF53-4ED9-8E43-DB0320782461Q43096427-DC6086E1-9214-4F1D-A139-23DEDB5641CEQ43132415-D58D2145-D65D-43A5-9697-C891B4063669Q49212311-4AADD1EB-E97B-4A00-BD1D-A7495FC26CFAQ54589324-D3327B3C-C7D0-4618-B202-8FA5DF3FF1A8Q55260577-B85549E1-9B61-4E26-8492-37F811ABD0EB
P2860
Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Novel soluble Flt-1 isoforms i ...... egnant and preeclamptic women.
@en
Novel soluble Flt-1 isoforms i ...... egnant and preeclamptic women.
@nl
type
label
Novel soluble Flt-1 isoforms i ...... egnant and preeclamptic women.
@en
Novel soluble Flt-1 isoforms i ...... egnant and preeclamptic women.
@nl
prefLabel
Novel soluble Flt-1 isoforms i ...... egnant and preeclamptic women.
@en
Novel soluble Flt-1 isoforms i ...... egnant and preeclamptic women.
@nl
P2093
P2860
P1433
P1476
Novel soluble Flt-1 isoforms i ...... regnant and preeclamptic women
@en
P2093
A Jeyabalan
A Rajakumar
R W Powers
P2860
P356
10.1016/J.PLACENTA.2008.10.006
P577
2008-11-17T00:00:00Z